nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Oedema—Cisplatin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Infection—Cisplatin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Hypotension—Fluorouracil—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Tachycardia—Cisplatin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Somnolence—Gemcitabine—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Somnolence—Fluorouracil—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Hypotension—Cisplatin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Fatigue—Gemcitabine—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Pain—Gemcitabine—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Asthenia—Thiotepa—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Infection—Etoposide—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Pruritus—Thiotepa—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Pain—Fluorouracil—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Paraesthesia—Cisplatin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Dyspnoea—Cisplatin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Pain—Cisplatin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Dizziness—Thiotepa—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Urticaria—Fluorouracil—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Gadodiamide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Gadodiamide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Vomiting—Thiotepa—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Rash—Thiotepa—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Dermatitis—Thiotepa—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Headache—Thiotepa—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Body temperature increased—Cisplatin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Pain—Etoposide—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Asthenia—Gemcitabine—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Pruritus—Gemcitabine—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Nausea—Thiotepa—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Pruritus—Fluorouracil—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000996	0.000996	CcSEcCtD
Gadodiamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000992	0.000992	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—urinary bladder cancer	0.00099	0.00099	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000987	0.000987	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—urinary bladder cancer	0.000979	0.000979	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—urinary bladder cancer	0.000979	0.000979	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—urinary bladder cancer	0.000979	0.000979	CcSEcCtD
Gadodiamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000975	0.000975	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—urinary bladder cancer	0.000973	0.000973	CcSEcCtD
Gadodiamide—Asthenia—Cisplatin—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000965	0.000965	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000957	0.000957	CcSEcCtD
Gadodiamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—urinary bladder cancer	0.000941	0.000941	CcSEcCtD
Gadodiamide—Chills—Methotrexate—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Gadodiamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000925	0.000925	CcSEcCtD
Gadodiamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000922	0.000922	CcSEcCtD
Gadodiamide—Rash—Gemcitabine—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Gadodiamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000912	0.000912	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—urinary bladder cancer	0.000911	0.000911	CcSEcCtD
Gadodiamide—Headache—Gemcitabine—urinary bladder cancer	0.000908	0.000908	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Gadodiamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Gadodiamide—Rash—Fluorouracil—urinary bladder cancer	0.000899	0.000899	CcSEcCtD
Gadodiamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000898	0.000898	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000897	0.000897	CcSEcCtD
Gadodiamide—Headache—Fluorouracil—urinary bladder cancer	0.000893	0.000893	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—urinary bladder cancer	0.00089	0.00089	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—urinary bladder cancer	0.000888	0.000888	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000886	0.000886	CcSEcCtD
Gadodiamide—Chills—Epirubicin—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000871	0.000871	CcSEcCtD
Gadodiamide—Nausea—Gemcitabine—urinary bladder cancer	0.000861	0.000861	CcSEcCtD
Gadodiamide—Vomiting—Cisplatin—urinary bladder cancer	0.000859	0.000859	CcSEcCtD
Gadodiamide—Rash—Cisplatin—urinary bladder cancer	0.000852	0.000852	CcSEcCtD
Gadodiamide—Dermatitis—Cisplatin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000847	0.000847	CcSEcCtD
Gadodiamide—Nausea—Fluorouracil—urinary bladder cancer	0.000847	0.000847	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—urinary bladder cancer	0.000839	0.000839	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000833	0.000833	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—urinary bladder cancer	0.000811	0.000811	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Gadodiamide—Nausea—Cisplatin—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000789	0.000789	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Gadodiamide—Rash—Etoposide—urinary bladder cancer	0.000781	0.000781	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—urinary bladder cancer	0.00078	0.00078	CcSEcCtD
Gadodiamide—Headache—Etoposide—urinary bladder cancer	0.000776	0.000776	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00077	0.00077	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—urinary bladder cancer	0.000767	0.000767	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—urinary bladder cancer	0.000764	0.000764	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—urinary bladder cancer	0.000762	0.000762	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000747	0.000747	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—urinary bladder cancer	0.000737	0.000737	CcSEcCtD
Gadodiamide—Infection—Methotrexate—urinary bladder cancer	0.000737	0.000737	CcSEcCtD
Gadodiamide—Nausea—Etoposide—urinary bladder cancer	0.000735	0.000735	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—urinary bladder cancer	0.000721	0.000721	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000717	0.000717	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—urinary bladder cancer	0.000708	0.000708	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—urinary bladder cancer	0.000694	0.000694	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000694	0.000694	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000691	0.000691	CcSEcCtD
Gadodiamide—Infection—Epirubicin—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Gadodiamide—Shock—Epirubicin—urinary bladder cancer	0.000683	0.000683	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—urinary bladder cancer	0.000682	0.000682	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000671	0.000671	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—urinary bladder cancer	0.000662	0.000662	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000661	0.000661	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—urinary bladder cancer	0.000659	0.000659	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000655	0.000655	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—urinary bladder cancer	0.000648	0.000648	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—urinary bladder cancer	0.000642	0.000642	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000642	0.000642	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—urinary bladder cancer	0.000639	0.000639	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—urinary bladder cancer	0.000638	0.000638	CcSEcCtD
Gadodiamide—Pain—Methotrexate—urinary bladder cancer	0.000634	0.000634	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000627	0.000627	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000621	0.000621	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—urinary bladder cancer	0.000617	0.000617	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000606	0.000606	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—urinary bladder cancer	0.0006	0.0006	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—urinary bladder cancer	0.000598	0.000598	CcSEcCtD
Gadodiamide—Pain—Epirubicin—urinary bladder cancer	0.000593	0.000593	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000572	0.000572	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000572	0.000572	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000571	0.000571	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000567	0.000567	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000565	0.000565	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000554	0.000554	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—urinary bladder cancer	0.000551	0.000551	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—urinary bladder cancer	0.000532	0.000532	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000529	0.000529	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000525	0.000525	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—urinary bladder cancer	0.000525	0.000525	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—urinary bladder cancer	0.00051	0.00051	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000507	0.000507	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—urinary bladder cancer	0.000498	0.000498	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—urinary bladder cancer	0.000491	0.000491	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—urinary bladder cancer	0.00049	0.00049	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000475	0.000475	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000473	0.000473	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—urinary bladder cancer	0.000471	0.000471	CcSEcCtD
Gadodiamide—Rash—Methotrexate—urinary bladder cancer	0.000468	0.000468	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—urinary bladder cancer	0.000467	0.000467	CcSEcCtD
Gadodiamide—Headache—Methotrexate—urinary bladder cancer	0.000465	0.000465	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000461	0.000461	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—urinary bladder cancer	0.000459	0.000459	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000454	0.000454	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—urinary bladder cancer	0.000441	0.000441	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—urinary bladder cancer	0.00044	0.00044	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000439	0.000439	CcSEcCtD
Gadodiamide—Rash—Epirubicin—urinary bladder cancer	0.000438	0.000438	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—urinary bladder cancer	0.000437	0.000437	CcSEcCtD
Gadodiamide—Headache—Epirubicin—urinary bladder cancer	0.000435	0.000435	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000425	0.000425	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—urinary bladder cancer	0.000412	0.000412	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000408	0.000408	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—urinary bladder cancer	0.000405	0.000405	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000404	0.000404	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—urinary bladder cancer	0.000402	0.000402	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—urinary bladder cancer	0.000381	0.000381	CcSEcCtD
